NEC OncoImmunity publishes research using its neoantigen prediction technology showing improved outcome in sarcoma patients treated with cancer immunotherapy
OSLO, Norway--(BUSINESS WIRE)--#cancer--NEC OncoImmunity AS (NOI) today announced it has published a study that describes the use of its artificial ...